搜尋結果
1 天前 · e23057 Background: Despite the decline in COVID-19–related hospitalizations and mortality during the period of omicron predominance, immunocompromised individuals, including those with cancer, remain at an increased risk for severe COVID-19 outcomes. A subanalysis of a retrospective observational cohort study assessed the relative vaccine effectiveness (rVE) of 2 previously approved bivalent ...
1 天前 · To establish the longitudinal cohort, we recruited 122 hospitalized patients with PCR-confirmed acute SARS-CoV-2 infection (47 moderate, 45 severe, and 30 critical) during the Omicron BA.5 wave in ...
1 天前 · In late 2022, because Omicron variants quickly dominated the global viral landscape, vaccine manufacturers accordingly developed original and Omicron BA.1 or BA.4/5 bivalent vaccines [4-6]. In 2023, Omicron XBB sublineages became responsible for a large proportion of COVID-19.
21 小時前 · 兒科醫師示警，腸病毒大多好發於10歲以下小孩，一般來說潛伏期平均約2至5天，且最凶猛、易致重症的病毒為71型。. 持續昏睡、持續嘔吐與肌躍型 ...
1 天前 · 本港百日咳個案增 持續劇烈咳嗽、喘鳴逾2星期應檢測 信件顯示，衛生防護中心今年截至23日共錄28宗百日咳個案，當中68%（19宗）涉嬰幼兒或兒童，其中3宗未滿6個月、即未完成接種3劑百日咳疫苗；至於其餘16宗兒童個案，15宗已完成接種疫苗，其餘一宗沒有明確接種史。
3 天前 · In this significant study, 20.2% of HCWs achieved seroprotection against Omicron subvariants BA.1, BA.4, and BA.5. Their immunity against Omicron subvariants was further reinforced through recommended vaccinations and the development of natural immunity from SARS-CoV-2 exposure, collectively enhancing their protection against Omicron.
21 小時前 · When administered as a 2 -dose primary series or a booster, the omicron BA.1 variant-containing COVID-19 vaccine (mRNA-1273.214) is immunogenic against BA.1 and D614G in children aged 6 months to ...
